During the past decade, evidence has accumulated indicating an associa
tion between endometriosis and changes in humoral and cell-mediated im
munity. However, it is not clear whether immune changes are the sequel
ae or play a role in the etiopathogenesis of the disease. The latter c
oncept is supported by the observation that exposure of rhesus monkeys
to radiation or immunotoxicants leads several years later to an incre
ase in frequency and severity of endometriosis. Studies from our labor
atories support the theory that endometrial cells misplaced during men
ses can implant in ectopic locations only in women with genetically or
environmentally altered cell-mediated immune function. Development of
endometriosis may then prompt a humoral response in some women, which
results in the production of autoantibodies to endometrial cells or c
ell-derived antigens. These autoantibodies may cross-react with the ut
erine endometrium, interfere with implantation, and cause infertility
or early spontaneous abortions. We recently observed that the presence
of autoantibodies in endometriosis was associated with significantly
lower in vitro fertilization/embryo transfer pregnancy rates. Interest
ingly, in about 30% of women with unexplained infertility, immune chan
ges characteristic of endometriosis were also present, suggesting a su
bclinical form of this disease. We conclude that: (1) women with unexp
lained infertility should have studies of the immune function to rule
out subclinical form of endometriosis; (2) evaluation of infertility i
n women with endometriosis should include an assessment of autoantibod
y status; and (3) treatment methods involving autoantibody suppression
should be considered in women with endometriosis positive for autoant
ibodies.